Repair Biotechnologies is Hiring a Senior Research Scientist / Project Lead in New York State to Speed Work on the Treatment of Aging

Bill Cherman and I founded Repair Biotechnologies earlier this year in order to work on a few carefully selected approaches to human rejuvenation, following the SENS philosophy of damage repair. If one can be involved in the hands-on work, then why not be involved in addition to cheering from the sidelines? So here we are, being involved. I will have a longer update on progress at Repair Biotechnologies next month; the short version for now is that (a) starting a company involves wading through a stupendous amount of learning, exploration, and setup work, and (b) things are going swimmingly.

We will be moving up to New York shortly to locate ourselves near Ichor Therapeutics, in LaFayette just outside Syracuse, and are now hiring our first scientific staff, beginning with a PhD level lead research scientist. The job posting is below; other positions will follow. If you know of scientists in your network who might be interested in an entrepreneurial role in helping to build some of the first working rejuvenation therapies, then please share this opportunity with them.

Repair Biotechnologies is a newly funded biotech startup developing treatments to reverse the progression of immunosenescence and atherosclerosis in old age. We are developing gene therapy and recombinant protein approaches to meaningfully address these widespread and harmful age-related conditions. Do you want to be involved in making an enormous positive difference to the lives of tens of millions of older patients? We have an immediate opening for our first technical lead in Lafayette, NY; a PhD with experience in molecular biology, gene therapy, cell and animal studies, able and proven to perform original research at the highest level of quality.

You will be helping us to define and complete our early stage development programs, working in the environment of an admired, busy, and expanding biotech incubator. You will design, execute, and troubleshoot cell and animal studies, in a critical position to guide the success of these programs as they move towards regulatory approval. You will be responsible for ensuring the quality and documentation of the work as it progresses. As new team members come on board, you will be setting a high bar and mentoring their development as researchers.

The ideal candidate will be detail oriented, recognize that we all live and die by the quality of our documentation, be able to produce quality work in a fast-paced and flexible environment, collaborate well with fellow scientists, and demonstrate the ability to learn and grow as our company expands to meet the challenges of building effective treatments to reverse aspects of aging. The qualifications:

  • PhD in cell biology, biochemistry, genetics, or related field (ABD acceptable).
  • Technical expertise in recombinant protein expression and/or viral vector production.
  • Experience in cell culture and assay development required.
  • Experience in husbandry, gene therapy, and biologic drug discovery and development are preferred but not required.
  • Must be able to operate independently and as a part of a team for execution of projects of varying scale.

LaFayette is a beautiful part of New York state with exceptional quality of life and low cost of living. Health benefits, competitive salary, and employee equity in the company are offered. Interested? Send your CV to


Nothing in this post should be construed as an offer to sell, or a solicitation of an offer to buy, any security or investment product. Certain information contained herein may contains statements, estimates and projections that are "forward-looking statements." All statements other than statements of historical fact in this post are forward-looking statements and include statements and assumptions relating to: plans and objectives of Repair Biotechnologies' management for future operations or economic performance; conclusions and projections about current and future economic and political trends and conditions; and projected financial results and results of operations. These statements can generally be identified by the use of forward-looking terminology including "may," "believe," "will," "expect," "anticipate," "estimate," "continue", "rankings" or other similar words. Repair Biotechnologies does not make any representations or warranties (express or implied) about the accuracy of such forward-looking statements. Accordingly, you should not place reliance on any forward-looking statements.


H1B for engineer from another country?

Posted by: Ariel at July 23rd, 2018 3:37 PM

We could support existing H1B transfers, but opening a new H1B is not feasible - it takes forever, and is quite likely not to work. Which is a pity, as there are a few people I know of in Europe and elsewhere we'd otherwise be happy to invite to work with us. The barriers seem higher these days than they have been in the past.

Posted by: Reason at July 23rd, 2018 3:43 PM

Reason, do you think to just place some work in university or lab in Europe or Russia?

Posted by: Ariel at July 23rd, 2018 4:41 PM

Or China? the equivalent PhD would cost ~1/4-1/7 as much as in the US

Posted by: Chris at July 23rd, 2018 5:24 PM

@Arial: We'll no doubt be doing that sort of thing in the future, but when you build a company at the very outset, you have to first hire the people who will work alongside you, same location.

Posted by: Reason at July 23rd, 2018 6:01 PM

Hi Reason,
You should also consider telecommuting and working with universities.

Canada is also not too far away and Canadian citizens don't need HB1, only TN1 as part of NAFTA. on top of that Montreal is only an hour away by flight from NY.

Posted by: Cuberat at July 23rd, 2018 6:04 PM

I have advertised this on our Facebook page. Good Luck :)

Posted by: Steve Hill at July 24th, 2018 8:31 AM

Glad to see my beautiful Upstate NY home getting another great company to open its doors there.

Posted by: DdR at July 24th, 2018 2:42 PM

What's the thinking behind being close to Ichor Therapeutics?

Posted by: Jim at July 24th, 2018 3:21 PM
Comment Submission

Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.